1
|
Funatsu H, Yamashita H, Nakamura S, Mimura
T, Eguchi S, Noma H and Hori S: Vitreous levels of pigment
epithelium-derived factor and vascular endothelial growth factor
are related to diabetic macular edema. Ophthalmology. 113:294–301.
2006. View Article : Google Scholar : PubMed/NCBI
|
2
|
Zhang GP, Han D, Liu G, Gao SG, Cai XQ,
Duan RH and Feng XS: Effects of soy isoflavone and endogenous
oestrogen on breast cancer in MMTV-erbB2 transgenic mice. J Int Med
Res. 40:2073–2082. 2012. View Article : Google Scholar : PubMed/NCBI
|
3
|
Gautam AK, Agarwal K, Shah BA, Kumar S and
Saiyed HN: Lead induced spermatoxicity in mouse and MPG treatment.
J Environ Biol. 22:287–291. 2001.PubMed/NCBI
|
4
|
Montorsi F, Adaikan G, Becher E, Giuliano
F, Khoury S, Lue TF, Sharlip I, Althof SE, Andersson KE, Brock G,
et al: Summary of the recommendations on sexual dysfunctions in
men. J Sex Med. 7:3572–3588. 2010. View Article : Google Scholar : PubMed/NCBI
|
5
|
Maiorino MI, Bellastella G and Esposito K:
Diabetes and sexual dysfunction: Current perspectives. Diabetes
Metab Syndr Obes. 7:95–105. 2014.PubMed/NCBI
|
6
|
Tamler R: Diabetes, obesity, and erectile
dysfunction. Gend Med. 6:4–16. 2009. View Article : Google Scholar : PubMed/NCBI
|
7
|
Thorve VS, Kshirsagar AD, Vyawahare NS,
Joshi VS, Ingale KG and Mohite RJ: Diabetes-induced erectile
dysfunction: Epidemiology, pathophysiology and management. J
Diabetes Complications. 25:129–136. 2011. View Article : Google Scholar : PubMed/NCBI
|
8
|
Zhang TT and Jiang JG: Active ingredients
of traditional Chinese medicine in the treatment of diabetes and
diabetic complications. Expert Opin Investig Drugs. 21:1625–1642.
2012. View Article : Google Scholar : PubMed/NCBI
|
9
|
Kevin L: Erectile dysfunction and
testosterone deficiency as gender-specific markers of
cardiometabolic risk in minority and non-minority men: Potential
role of social determinants. Mens Health. 9:139–145. 2012.
View Article : Google Scholar
|
10
|
Junuzovic D, Hasanbegovic M and Masic I:
Risk factors for erectile dysfunction in patients with newly
diagnosed diabetes mellitus. Med Arh. 64:345–347. 2010. View Article : Google Scholar : PubMed/NCBI
|
11
|
Bukovsky A: Novel methods of treating
ovarian infertility in older and POF women, testicular infertility,
and other human functional diseases. Reprod Biol Endocrinol.
13:102015. View Article : Google Scholar : PubMed/NCBI
|
12
|
Dhindsa S, Prabhakar S, Sethi M,
Bandyopadhyay A, Chaudhuri A and Dandona P: Frequent occurrence of
hypogonadotropic hypogonadism in type 2 diabetes. J Clin Endocrinol
Metab. 89:5462–5468. 2004. View Article : Google Scholar : PubMed/NCBI
|
13
|
Pitteloud N, Hardin M, Dwyer AA, Valassi
E, Yialamas M, Elahi D and Hayes FJ: Increasing insulin resistance
is associated with a decrease in Leydig cell testosterone secretion
in men. J Clin Endocrinol Metab. 90:2636–2641. 2005. View Article : Google Scholar : PubMed/NCBI
|
14
|
Cregan SP, Dawson VL and Slack RS: Role of
AIF in caspase-dependent and caspase-independent cell death.
Oncogene. 23:2785–2796. 2004. View Article : Google Scholar : PubMed/NCBI
|
15
|
Hayashi K, Kojima R and Ito M: Strain
differences in the diabetogenic activity of streptozotocin in mice.
Biol Pharm Bull. 29:1110–1119. 2006. View Article : Google Scholar : PubMed/NCBI
|
16
|
Cory S, Huang DCS and Adams JM: The Bcl-2
family: Roles in cell survival and oncogenesis. Oncogene.
22:8590–8607. 2003. View Article : Google Scholar : PubMed/NCBI
|
17
|
Song W, Liu MG, Zhang JB, Zhang JJ, Sun MM
and Yu QK: Mechanism of action of EBV, Bcl-2, p53, c-Myc and Rb in
non-Hodgkins lymphoma. Eur Rev Med Pharmacol Sci. 20:1093–1097.
2016.PubMed/NCBI
|
18
|
Brady HJ and Gil-Gómez G: Bax. The
pro-apoptotic Bcl-2 family member, Bax. Int J Biochem Cell Biol.
30:647–650. 1998. View Article : Google Scholar : PubMed/NCBI
|
19
|
Lu QL, Abel P, Foster CS and Lalani EN:
bcl-2: Role in epithelial differentiation and oncogenesis. Hum
Pathol. 27:102–110. 1996. View Article : Google Scholar : PubMed/NCBI
|
20
|
Hikim AP Sinha, Lue Y, Diaz-Romero M, Yen
PH, Wang C and Swerdloff RS: Deciphering the pathways of germ cell
apoptosis in the testis. J Steroid Biochem Mol Biol. 85:175–182.
2003. View Article : Google Scholar : PubMed/NCBI
|
21
|
Furuchi T, Masuko K, Nishimune Y, Obinata
M and Matsui Y: Inhibition of testicular germ cell apoptosis and
differentiation in mice misexpressing Bcl-2 in spermatogonia.
Development. 122:1703–1709. 1996.PubMed/NCBI
|
22
|
Tapanainen JS, Tilly JL, Vihko KK and
Hsueh AJ: Hormonal control of apoptotic cell death in the testis:
Gonadotropins and androgens as testicular cell survival factors.
Mol Endocrinol. 7:643–650. 1993. View Article : Google Scholar : PubMed/NCBI
|